Patent · US Active

Treprostinil derivatives and compositions and uses thereof

US10246403B2 · kind B2 · utility

19Cited by

70References

18Claims

0Family size

Assignee

Corsair Pharma, Inc. · US

Inventors

Xiaoming Zhang · Beijing, CN
Meenakshi S. Venkatraman · Fremont, US
Cyrus K. BECKER · Fremont, US

Key dates

Filing date	Jun 14, 2016
Grant date	Apr 2, 2019
Priority date	—
Expiry date	Jun 14, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2603/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.